This trial is evaluating whether Treatment will improve 1 primary outcome, 2 secondary outcomes, and 6 other outcomes in patients with Hepatitis C. Measurement will happen over the course of 1 day from ED visit.
This trial requires 165000 total participants across 0 different treatment group
Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.
In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.